Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On Tuesday 17th April 2018, the Department of Physiology Anatomy and Genetics (DPAG) officially opened its new Centre for Integrative Neuroscience, and Sir Colin Blakemore was here to pull the curtain on the commemorative plaque. 

The event was celebrated with a drinks and canapes reception in the Sherrington foyer, and marked by the inaugural Sir Charles Sherrington Lecture.

The Centre for Integrative Neuroscience has been established as part of the Department's ongoing re-organisation and is to be located in the east wing of the Sherrington Building, extending into the adjacent Henry Wellcome Building.

The focus of this centre will be a multidisciplinary study of mammalian neural circuits, which will bring together DPAG's world leading expertise in the investigation of how the cells of the nervous system are formed, migrate into position, and assemble into specific circuits, how those cells communicate with each other and encode information, and how the circuits they form give rise to behaviour.

Blakemore, now an Emeritus Professor of DPAG, was formerly Head of Department and Waynflete Professor of Physiology. His contribution to neuroscience is the part he played in establishing the concept of neural plasticity, the capacity of the brain to reorganise itself as a result of the pattern of activity passing through its connections, the subject of the Sir Charles Sherrington Lecture this year.

To view more pictures from the event, click here.

In case you weren't able to make the event, you can watch some highlights below.

Similar stories

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

The ALBA Declaration

Strategic Developments

Improving Equality, Diversity and Inclusiveness.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.